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Objective: This study aimed to investigate the potential of vitamin B3 to promote the conversion of stem
cells to mature central nervous system (CNS) neurons.
Background: Vitamin B3 has been shown to play an important role during embryogenesis. Speci cally, there
is growing evidence that nicotinamide, the biologically active form of vitamin B3, plays a critical role as a
morphogen in the differentiation of stem cells to mature cell phenotypes, including those of the CNS.
Nicotinamide levels must be tightly regulated, with excess leading to neural damage, and de ciency leading
to the condition, Pellagra, which manifests in a number of neural symptoms similar to Parkinson’s. Detailed
knowledge of the action of small molecules during neuronal differentiation is not only critical for uncovering
mechanisms underlying lineage-speci cation, but also to establish more effective differentiation protocols to
obtain clinically relevant cells for regenerative therapies for neurodegenerative conditions such as
Parkinson’s disease.
Methods: Nicotinamide was applied to developing mouse embryonic stem cells (mESCs) during their
conversion towards a neural fate. Cells were assessed for survival, proliferation, differentiation and
maturation.
Results: In the presence of an optimal dose of nicotinamide (10 mM), mESCs showed accelerated neural and
neuronal differentiation, to yield higher numbers of dopamine neurons. Nicotinamide was shown to act in a
dose-dependent manner in a de ned time-window – with high doses (20mM) however causing toxicity. The
mechanism of nicotinamide’s action was through reduction in cell proliferation (i.e. cell cycle exit), rather than
increased survival of neural progenitors. Nicotinamide alone was suf cient to generate dopaminergic
neurons in similar numbers to current cell culture additives that have been used in previously published
methods.
Conclusions: Our results show that, within an optimal dose range, nicotinamide is able to positively in uence
the conversion of embryonic stem cells to dopamine neurons, and therefore may be a critical factor for
normal brain development. Thus, nicotinamide may offer a simple effective alternative supplement to
enhance the use of stem cells as therapeutics for Parkinson’s. An optimal maternal to foetal dietary dosage of
nicotinamide – neither too low nor too high – could also be linked to protection from Parkinson’s disease
later in life.
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